Compliance with the recommendations given by the CNPI is presented: PCV13 since July 1, cohort born May 1, 2022. This progress contributes to the WHO strategy of "Defeating meningitis by 2030"; The 4th dose of IPV from June 1, 2022.

Colombia will purchase 5,600 doses; The vaccine will be distributed 80% for outbreaks and contacts and 20% to
the population at risk; The 5,600 doses will be applied intradermally so that the doses to be applied will be 28,000 doses for 14 thousand people vaccinated with two doses.

CNPI recommends continuing the Measles and Rubella campaign until the coverage goal of more than 2 million children has reached 95%; Once the catch-up campaign has been completed, change the booster from 5 years to 18 months; Recommends switching from PCV 10 to PCV 13 during the Week of the Ameri